TBPMF News and Press, Tetra Bio-Pharma Inc From 03/03/21

OTTAWA, ON / ACCESSWIRE / March 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) , a biopharmaceutical pioneer in immunomodulator drug discovery and development announces that CEO Dr. Guy Chamberland will present a company overview and hold virtual inves...

Tetra Bio-Pharma Announces Closing of Bought Deal Offering Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA, ON , March 2, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. (" Tetra ...

Company signs LOI for Nordics and Germany OTTAWA, ON / ACCESSWIRE / February 25, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) , a biopharmaceutical pioneer in immunomodulator drug discovery and development announced the signing of a Letter of Inten...

Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of Units Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA, ON , Feb. 22, 2021 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra B...

Tetra Bio-Pharma Inc. Announces Closing of Non-Brokered Private Placement Canada NewsWire OTTAWA, ON , Feb. 3, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. (" Tetra Bio-Pharma " or the " Company ") (TSX: TBP) (OTCQB: TBPMF), a leader in cannabinoid-deri...

OTTAWA, ON / ACCESSWIRE / February 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP )( OTCQB:TBPMF ), a biopharmaceutical pioneer in immunomodulator drug discovery and development announced today the creation of a wholly-owned subsidiary called ENJOUCA™. Jur...

Tetra Bio-Pharma ([[TBPMF]] +9.8%) announces that the U.S. FDA has cleared its Investigational New Drug application to initiate its QIXLEEF Reborn1 clinical trial in cancer patients with breakthrough pain.Reborn1 is a 10-week open-label randomized study to evaluate the effect o...

OTTAWA, ON / ACCESSWIRE / January 29, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:TBP ) ( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development announced today that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigation...

Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement Canada NewsWire OTTAWA, ON , Jan. 27, 2021 /CNW Telbec/ - Tetra Bio-Pharma Inc. (" Tetra Bio-Pharma " or the " Company ") (TSX: TBP) (OTCQB: TBPMF), a leader in cannabinoid-derived drug...

Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...